Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction
Heart, Lung and Circulation · 2023
DOI: 10.1016/j.hlc.2023.04.299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2023. Verfasst von Simon Rocheleau und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine & Public Health, Flinders University of South Australia, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Myocardial Infarction, Acute Coronary Syndrome, Heart Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Roche, Edwards Lifesciences.
Abstract (Originalsprache)
BACKGROUND: Diagnosis of acute myocardial infarction (AMI) requires a combination of elevated cardiac troponins, and clinical or echocardiographic evidence of coronary ischaemia. Identification of patients with a high likelihood of coronary plaque rupture (Type 1 myocardial infarction [MI]) is crucial as it is these patients for whom coronary intervention has been well-established to provide benefit and reduce subsequent coronary ischemic events. However, high-sensitivity cardiac troponin (hs-cTn) assays have increasingly identified patients with hs-cTn elevations not due to Type 1 MI where recommendations for ongoing care are currently limited. Understanding the profile and clinical outcomes for these patients may inform the development of an emerging evidence-base. METHODS: Using two previously published studies (hs-cTnT study n=1,937, RAPID-TnT study n=3,270) and the Fourth Universal Definition of MI, index presentations of patients to South Australian emergency departments with suspected AMI, defined by high sensitivity cardiac troponin T (hs-cTnT) greater than the upper reference limit (14 ng/L) and without obvious corresponding ischaemia on electrocardiogram (ECG), were classified as either Type 1 MI (T1MI), Type 2 MI (T2MI), acute myocardial injury (AI), or chronic myocardial injury (CI). Patients with non-elevated hs-cTnT (defined as
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine & Public Health, Flinders University of South Australia, Adelaide, SA, Australia.
- College of Medicine & Public Health, Flinders University of South Australia, Adelaide, SA, Australia; South Australian Department of Health, Adelaide, SA, Australia.
- College of Medicine & Public Health, Flinders University of South Australia, Adelaide, SA, Australia; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
- University of Adelaide, Adelaide, SA, Australia.
- College of Medicine & Public Health, Flinders University of South Australia, Adelaide, SA, Australia; South Australian Health and Medical Research Institute, Adelaide, SA, Australia; South Australian Department of Healt…
Förderung
- Roche
- Edwards Lifesciences
Zitieren
APA
Rocheleau, S., Eng-Frost, J., Lambrakis, K., Khan, E., Chiang, B., Wattchow, N., Steele, S., Lorensini, S., Lehman, S. J., Papendick, C., & Chew, D. P. (2023). Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2023.04.299
Vancouver
Rocheleau S, Eng-Frost J, Lambrakis K, Khan E, Chiang B, Wattchow N, et al. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction. Heart, Lung and Circulation. 2023. doi:10.1016/j.hlc.2023.04.299
BibTeX
@article{Rocheleau2023,
author = {Rocheleau, Simon and Eng-Frost, Joanne and Lambrakis, Kristina and Khan, Ehsan and Chiang, Brian and Wattchow, Naomi and Steele, Simon and Lorensini, Scott and Lehman, Sam J and Papendick, Cynthia and Chew, Derek P},
title = {Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction},
journal = {Heart, Lung and Circulation},
year = {2023},
doi = {10.1016/j.hlc.2023.04.299}
}
EUVIMED